Levofree Teva

Levodropropizine, the active ingredient in Levofree Teva, is an antitussive presented as an oral formulation for oral use. It suppresses dry and non‑productive coughs by acting on sensory nerves in the respiratory tract, providing symptomatic relief for patients with irritative cough. It is indicated for the symptomatic management of cough in adults and children over a certain age, where the cough is not productive.

GNH USA supplies Levofree Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Levodropropizine is used as a peripheral antitussive to reduce cough reflex in the respiratory tract. - Dry cough: Reduces frequency and intensity of non‑productive cough. - Irritative cough: Provides symptomatic relief by dampening sensory nerve activation. - Cough associated with upper respiratory infections: Helps control cough without affecting mucus clearance.

Levodropropizine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset. - Dizziness: transient light‑headedness. - Taste alteration: unusual taste perception. - Headache: mild to moderate.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Hepatic dysfunction: elevated liver enzymes. - Severe neutropenia: low white blood cell count.

Levofree should be used with attention to specific safety considerations. - Pregnancy: safety not established; avoid unless clearly needed. - Breastfeeding: unknown risk; consider alternatives. - Pediatric use: use only in children above the age specified by the prescriber. - Concomitant medications: review for potential interactions, especially CNS depressants. - Renal impairment: dose adjustment may be required in severe cases. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Levofree may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase plasma levels of levodropropizine. - MAO inhibitors: risk of enhanced central nervous system effects.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., antihistamines, sedatives): may increase dizziness. - Anticholinergic agents: may potentiate dry mouth. - Other antitussives: additive cough suppression may mask underlying conditions.